» Articles » PMID: 12574072

Impact of Randomized Trial Results on Acute Lung Injury Ventilator Therapy in Teaching Hospitals

Overview
Specialty Critical Care
Date 2003 Feb 8
PMID 12574072
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Reducing tidal volumes administered to patients with acute lung injury is the only intervention reported to decrease mortality resulting from this life-threatening condition. Whereas many medical advances are slowly brought into practice, clinicians in teaching hospitals are often assumed to be early adopters of new medical advances. Our objective was to examine trends in the ventilatory prescription for 398 patients with acute lung injury treated in three teaching hospitals from 1994 to 2001. There was no change in tidal volumes until mid to late 1998, when volumes started to slowly decline at the rate of 48.0 (95% confidence interval, 21.0 to 74.4) ml/year. In the 2 years after the results were released from a large trial that demonstrated the superiority of 6 ml/kg tidal volume therapy over 12 ml/kg, clinicians prescribed tidal volumes of 651 +/- 128 ml or 10.1 +/- 1.9 ml/kg. Tidal volumes after intubation were minimally reduced over the subsequent 2 days of mechanical ventilation (mean reduction, 33 ml). Hospital category, male sex, and disease onset before May 1999 were associated with higher volumes whereas lung injury severity was inversely associated. We conclude that clinicians practicing at these teaching hospitals have not rapidly adopted low tidal volume ventilation that may reduce mortality.

Citing Articles

Corticosteroid Uptake For COVID-19 after Publication of RECOVERY: A Difference in Difference Model.

Kearney C, Lesieur M, Bosch N, Walkey A Ann Am Thorac Soc. 2022; 20(3):473-476.

PMID: 36525470 PMC: 9993153. DOI: 10.1513/AnnalsATS.202208-715RL.


Pazopanib Is a Potential Treatment for Coronavirus-Induced Lung Injuries.

Luan Y, Yuan Q, Wang Q, Compton S, Wu D, Tang W J Immunol. 2022; 209(4):723-730.

PMID: 35914834 PMC: 9378470. DOI: 10.4049/jimmunol.2100968.


The first step is recognizing there is a problem: a methodology for adjusting for variability in disease severity when estimating clinician performance.

Bechel M, Pah A, Persell S, Weiss C, Nunes Amaral L BMC Med Res Methodol. 2022; 22(1):69.

PMID: 35296240 PMC: 8924737. DOI: 10.1186/s12874-022-01543-7.


Impact of Clinician Recognition of Acute Respiratory Distress Syndrome on Evidenced-Based Interventions in the Medical ICU.

Kerchberger V, Brown R, Semler M, Zhao Z, Koyama T, Janz D Crit Care Explor. 2021; 3(7):e0457.

PMID: 34250497 PMC: 8263322. DOI: 10.1097/CCE.0000000000000457.


Promoting Evidence-Based Practice in Acute Respiratory Distress Syndrome: A Systematic Review.

Giovanni S, Jennerich A, Steel T, Lokhandwala S, Alhazzani W, Weiss C Crit Care Explor. 2021; 3(4):e0391.

PMID: 33912832 PMC: 8078296. DOI: 10.1097/CCE.0000000000000391.